WEST CONSHOHOCKEN, Pa., May 6, 2025 /PRNewswire/ -- PRM Pharma, LLC today announced the U.S. Food and Drug Administration (FDA) approval of HemiClor (12.5 mg chlorthalidone) tablets for the treatment ...
CRANFORD, N.J., March 2 /PRNewswire/ -- Actavis U.S., the United States manufacturing and marketing division of the international generic pharmaceutical company Actavis Group (ICEX: ACT), announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results